Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The antimicrobial protection hypothesis of Alzheimer's disease
Robert D. Moir, Richard Lathe, Rudolph E. Tanzi
Alzheimer s & Dementia (2018) Vol. 14, Iss. 12, pp. 1602-1614
Closed Access | Times Cited: 369

Showing 1-25 of 369 citing articles:

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long, David M. Holtzman
Cell (2019) Vol. 179, Iss. 2, pp. 312-339
Open Access | Times Cited: 2330
Antibiotics, gut microbiota, and Alzheimer’s disease
Francesco Angelucci, Kateřina Čechová, Jana Amlerová, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 371
Fecal Microbiota Transplantation in Neurological Disorders
Karuna E.W. Vendrik, Rogier E. Ooijevaar, Pieter R. C. de Jong, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 325
The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
Sarah Kent, Tara L. Spires‐Jones, Claire S. Durrant
Acta Neuropathologica (2020) Vol. 140, Iss. 4, pp. 417-447
Open Access | Times Cited: 311
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease
Moira Marizzoni, Annamaria Cattaneo, Peppino Mirabelli, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 683-697
Open Access | Times Cited: 246
The Microbiome as a Modifier of Neurodegenerative Disease Risk
Ping Fang, Sabeen A. Kazmi, Kelly G. Jameson, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 2, pp. 201-222
Open Access | Times Cited: 185
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Elisabetta Vegeto, Alessandro Villa, Sara Della Torre, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 273-319
Open Access | Times Cited: 174
The neuroimmune axis of Alzheimer’s disease
Mehdi Jorfi, Anna Maaser-Hecker, Rudolph E. Tanzi
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 165
Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort
Pyry N. Sipilä, Nelli Heikkilä, Joni V. Lindbohm, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1557-1567
Open Access | Times Cited: 122
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Dong-oh Seo, David M. Holtzman
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 86-94
Open Access | Times Cited: 75
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
Markku Kurkinen, Michał Fułek, Katarzyna Fułek, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 453-453
Open Access | Times Cited: 44
The endotoxin hypothesis of Alzheimer’s disease
Guy C. Brown, Michael T. Heneka
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 19
Microglial activation states and their implications for Alzheimer's Disease
Zachary Valiukas, Kathy Tangalakis, Vasso Apostolopoulos, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 3
Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
Anna Onisiforou, Eleftheria G. Charalambous, Panos Zanos
Microorganisms (2025) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 2
Time to test antibacterial therapy in Alzheimer’s disease
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Brain (2019)
Open Access | Times Cited: 140
Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity
Kevin Mullane, Michael Williams
Current Protocols in Pharmacology (2019) Vol. 84, Iss. 1
Closed Access | Times Cited: 111
Periodontal disease as a possible cause for Alzheimer's disease
Angela R. Kamer, Ronald G. Craig, Richard Niederman, et al.
Periodontology 2000 (2020) Vol. 83, Iss. 1, pp. 242-271
Closed Access | Times Cited: 111
Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease
Morgane Linard, Luc Letenneur, Isabelle Garrigue, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 1, pp. 200-208
Open Access | Times Cited: 106
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Navid Rabiee, Sepideh Ahmadi, Ronak Afshari, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 3
Closed Access | Times Cited: 102
Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects
William C. Bushell, Ryan Castle, Michelle A. Williams, et al.
The Journal of Alternative and Complementary Medicine (2020) Vol. 26, Iss. 7, pp. 547-556
Open Access | Times Cited: 94
The role of innate immunity in Alzheimer's disease
Hannah E. Ennerfelt, John R. Lukens
Immunological Reviews (2020) Vol. 297, Iss. 1, pp. 225-246
Open Access | Times Cited: 93
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Amanda L. Miller, Shingo Bessho, Kaitlyn Grando, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 89
Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2020) Vol. 177, pp. 113945-113945
Closed Access | Times Cited: 84
Page 1 - Next Page

Scroll to top